Microglia are the main immune cells of the brain and contribute to common brain diseases. However, it is unclear how microglia influence neuronal activity and survival in the injured brain in vivo. Here we develop a precisely controlled model of brain injury induced by cerebral ischaemia combined with fast in vivo two-photon calcium imaging and selective microglial manipulation. We show that selective elimination of microglia leads to a striking, 60% increase in infarct size, which is reversed by microglial repopulation. Microglia-mediated protection includes reduction of excitotoxic injury, since an absence of microglia leads to dysregulated neuronal calcium responses, calcium overload and increased neuronal death. Furthermore, the incidence of spreading depolarization (SD) is markedly reduced in the absence of microglia. Thus, microglia are involved in changes in neuronal network activity and SD after brain injury in vivo that could have important implications for common brain diseases.
Microglia are the main resident immune-competent cell population of the central nervous system (CNS), and play an essential role in CNS development, maintenance and repair1. However, altered microglial activity is associated with common human diseases, such as migraine, stroke, dementia, traumatic injury, epilepsy and Parkinson’s disease: these affect millions of people worldwide, representing a high socioeconomic burden2,3,4. In fact, microglia are capable of producing a diverse array of inflammatory mediators in response to injury or infection, and inflammation is linked with poor clinical outcome in CNS diseases3,4,5. At the same time, data also indicate that specific microglial actions can be neuroprotective6. Thus, the role of microglia in brain injury is controversial and disease dependent, whereas the mechanisms through which microglia contribute to brain injury or repair are unclear.
Microglia are highly dynamic, and constantly survey the brain parenchyma, showing rapid activation in response to harmful stimuli7. In vivo two-photon imaging studies have revealed that microglial processes interact with capillaries, react to vascular or parenchymal injury in the brain, monitor the state of synapses and remove injured neurons, their processes or synaptic structures in different models of brain injury7,8,9,10,11. Recently, microglia have also been shown to react to changes in extracellular calcium levels12. It is currently debated whether microglia could promote excitotoxicity (a major cause of neuronal death induced by calcium overload) via production of proinflammatory mediators13,14, or whether specific microglial actions could reduce excitotoxic neuronal death15,16. It is also unclear whether microglia could play a role in spreading depolarization (SD), one of the most fundamental processes of brain pathology17 that involves swelling of neurons, injury to dendritic spines and subsequent silencing of brain electrical activity, which is linked with excitotoxicity and general outcome in common brain diseases such as stroke, brain haemorrhage, epilepsy and migraine18,19,20. However, the functional role of microglia in shaping the activity of complex neuronal networks is difficult to study in vivo, since the large similarity between microglia and other tissue macrophages has not allowed selective in vivo manipulation of microglia until very recently6,21. Also, it has proved to be difficult to perform long-term monitoring of fast neuronal responses in the context of microglial activity in real time.
Microglia arise from yolk sac-derived precursors that populate the brain during early development21. Microglia genesis is dependent on the transcription factors IRF8 and PU.1 (ref. 22), but, once migrated to the neuroectoderm, microglia become self-renewing, which requires colony-stimulating factor 1 receptor (CSF1R)-dependent signalling23. High-dose treatment with a brain-penetrant CSF1R kinase inhibitor reversibly depletes microglia, an effect that has no apparent gross deleterious results in healthy mice, but that provides a powerful tool for inferring the various roles of microglia in more detail24.
Strikingly, we found that selective elimination of microglia from the brain leads to markedly augmented neuronal death after acute brain injury. To study the mechanisms involved, we combined fast multicolour two-photon imaging of genetically encoded calcium indicators (GECI) with a recently developed remote filament model of middle cerebral artery occlusion (MCAo) allowing us to monitor microglial responses and fast neuronal activity changes simultaneously, in real time. We show that an absence of microglia results in dysregulated neuronal responses, lack of SD and increased excitotoxic injury. Thus, supporting beneficial microglial–neuronal interactions could have profound therapeutic implications.
CSF1R blockade leads to selective microglia depletion
Microglia have been implicated in both vascular9,25 and neuronal injury26,27, and neuroprotection28,29, but tools to selectively manipulate microglia have become available only very recently24,30,31. To reduce the potential side effects of microglia manipulation to the minimum, we made use of the discovery that microglial survival is critically dependent on CSF1R signalling, in contrast to other tissue macrophages23,24,31. Feeding a chow diet containing the CSF1R antagonist PLX3397 (290 p.p.m.) for 3 weeks resulted in an almost complete elimination of microglia from the brain in Cx3Cr1GFP/+mice, as confirmed by the absence of green fluorescent protein (GFP)-positive cells that co-expressed the microglia/macrophage marker Iba1 (Fig. 1a). Quantitative analysis showed that after 3 weeks, 97% of microglia were eliminated from the cerebral cortex and 93% from the striatum, compared with control mice (Fig. 1b). Microglia were eliminated as a result of apoptosis, as indicated by the expression of the apoptotic marker Cleaved Caspase-3 in microglia, but not in neurons (Fig. 1c) or other cells (not shown). Correspondingly, no sign of brain inflammation, leukocyte recruitment, weight loss or increases in circulating inflammatory citokines were observed over 3 weeks of PLX3397 treatment (Supplementary Fig. 1), confirming previous results24,32. No sign of blood brain barrier (BBB) injury, as assessed by IgG penetration into the brain parenchyma was found similarly to earlier observations24. The number of neurons, pericytes, astrocytes and levels of the tight junction protein claudin 5 were not altered in the brain (Supplementary Fig. 2a, b) and no changes were seen in spleen macrophages and splenic or blood leukocyte populations (Supplementary Figs 3 and 4). Thus, we argued that this model of selective microglial ablation introduces minimal disturbance to the brain and does not alter peripheral leukocytes, enabling us to study the role of microglia in brain injury.
Absence of microglia results in increased brain injury
Next, we designed a series of experiments to assess the role of microglia in brain injury and to control for the potential confounding effects PLX3397 might exert on neuronal injury. As earlier, an almost complete elimination of microglia (Iba1+ cells) from the brain was observed after feeding mice a chow diet containing PLX3397 for 21 days (Fig. 1d). Since PLX3397 is quickly cleared from central and peripheral tissues24, the PLX3397 diet was withdrawn for 24 h after 21 days of microglia depletion in a separate group of animals, after which microglia remained fully depleted, but only trace amounts of the drug were detected in the brain24. Indeed, we found that 98% of microglia were absent from the cerebral cortex 24 h after drug withdrawal (Fig. 1d). In a further group of animals, the drug was withdrawn for 2 weeks after 21 days of treatment, which led to full repopulation of microglia (Fig. 1d). No changes in splenic Iba1+ macrophages were seen in any of the experimental groups (Fig. 1e). The absence of microglia resulted in a striking, 60% increase in infarct size 24 h after MCAo (26.8 mm3 in control versus 42.8 mm3 in microglia-depleted animals), which was not affected by the presence of PLX3397, as increased infarct size (41.2 mm3) was also seen if PLX3397 was withdrawn 24 h before cerebral ischaemia (Fig. 1f). In contrast, repopulation of microglia completely reversed the effect of microglia depletion on increased infarct size (22.5 mm3), implying that the presence of microglia influences the severity of brain injury after cerebral ischaemia. We also investigated whether any of the treatment protocols affected cerebral blood flow (CBF), but no differences in CBF values were found after occlusion of the MCA (Fig. 1g) or at reperfusion (not shown) compared with baseline. Levels of interleukin 6 (IL-6)—a cytokine produced by microglia1—in the cerebrospinal fluid mirrored the differences seen in microglial numbers across the different experimental groups 24 h after cerebral ischaemia (Fig. 1h). Absence of microglia did not lead to increased leukocyte recruitment to the brain 24 h (Fig. 1i) and 72 h (Supplementary Fig. 5) after cerebral ischaemia or inflammation as observed previously by others after hippocampal injury24. In addition, Iba1-positive microglia/macrophages were still profoundly reduced in the brain 72 h after MCAo, suggesting that an absence of microglia (and larger brain injury) does not lead to significantly increased monocyte influx compared with control mice. We also investigated whether a single, intraperitoneal injection of 20 mg kg−1 PLX3397, which resulted in 25,930±3,600 ng ml−1 PLX3397 concentrations in the plasma and 1,160±290 ng g−1 (2.8±0.7 μM) concentrations in the intact (non-ischaemic) brain tissue (Supplementary Fig. 6) could exert any effect on neuronal injury. This regimen yields higher PLX3397 levels than that needed to maintain depletion of microglia24, but does not lead to microglia depletion. Mice that received a single, acute dose of 20 mg kg−1 PLX3397 60 min after MCAo, when BBB injury takes place based on our two-photon imaging data (see below), showed no changes in infarct size 24 h after reperfusion compared with controls (Fig. 1j), while microglial numbers were not reduced (Supplementary Fig. 6). Thus, these data suggest that an absence of microglia leads to increased brain injury independently of PLX3397 and that PLX3397 itself has no detrimental effect on neuronal injury in this model.
Absence of microglia facilitates excitotoxicity
Next, we used in vivo two-photon calcium imaging combined with a recently developed remote filament model of MCAo to investigate the mechanisms through which microglia contribute to brain protection after acute injury. To this end, adeno-associated virus (AAV)-mediated delivery of the GECIs, GCaMP6s or RCaMP1 was performed using a micropipette distant from the imaging site. This minimized disturbance to the brain tissue, as evidenced by the absence of microglial activation in the imaging area where the dura mater was not injured (see Methods section and Supplementary Fig. 7a). This system enabled precise and continous monitoring of neuronal calcium changes and network activity in the cerebral cortex in real time, up to several hours post reperfusion (Fig. 2a). In a separate set of experiments, series of CBF measurements were performed by laser Doppler flowmetry to establish the site of our imaging window (30 measurements performed in n=5 mice). To capture neuronal GCaMP6s signal changes in the evolving infarct, the imaging site was positioned between an area with close to maximal CBF reduction (80% reduction to baseline) and an area with sub-ischaemic levels of blood flow (30% reduction to baseline, Fig. 2b). In response to induction of cerebral ischaemia for 60 min, we noticed minor increases of the GCaMP6s signal in cortical neurons and the neuropil followed by low levels of GCaMP6s signal up to 1–1.5 h after the induction of reperfusion (Fig. 2c,d). In contrast, a marked increase in intracellular calcium was observed 1.5–3 h after reperfusion in the same neurons and the neuropil caused by the initiation of SD, a basic phenomenon of brain pathology thought to contribute to excitotoxicity and linked with neuronal injury in diverse neurological diseases18,20 (Fig. 2d,e and Supplementary Video 1). Series of two to four SDs in individual mice were followed by a reduction in neuronal calcium signals by 4 h of reperfusion (Fig. 2d–f), which remained similar 24 h after cerebral ischaemia (Supplementary Fig. 7B). Quantitative analysis of GCaMP6s signal changes over time showed that significant increases in neuronal calcium levels develop only 1.5–3 h after the induction of reperfusion due to repeated SDs (Fig. 2f). The GCaMP6s signal remained unaltered in sham animals over the whole imaging period.
Microglia contact neurons in an activity-dependent manner
Several excellent previous studies have investigated microglial responses after brain injury using two-photon microscopy1,7,8,10, but in vivo two-photon imaging to evaluate the relationship between microglial actions and neuronal network activity has not been performed in real time. Our histological data suggested that after cerebral ischaemia, microglia and their processes surround neurons showing high GCaMP6s signal in the boundary zones of the infarct (Fig. 3a). To investigate this in real time, neuronal calcium responses were monitored with two-photon microscopy using the GECI RCaMP1, in Cx3Cr1GFP/+ (microglia reporter) mice (Fig. 3b). Cerebral ischaemia resulted in similar RCaMP1 changes as seen earlier with GCaMP6s. Morphological signs of microglial activation (reduced ramification and thickened processes) were seen between 1 and 4 h after the onset of ischaemia in the evolving infarct as also confirmed by Sholl analysis33. Microglial activation was associated with enlargement of the cell body and increased Iba1 expression from 6 h after cerebral ischaemia (Supplementary Fig. 8). Importantly, microglial processes, which were frequently found to touch neuronal cell bodies and dendrites already before MCAo, were extended to neurons showing increasing RCaMP1 signal over time, surrounding the cell body and the main dendrites, whereas microglial processes were withdrawn after prolonged reduction in neuronal intracellular calcium levels (Fig. 3b–d and Supplementary Video 2). We also assessed changes in the density of microglial processes in concentric circles around individual neurons (a modification of Sholl analysis33, see Methods section), which showed increasing microglial process coverage (R2=0.9, P=0.0038) of neurons showing a sustained rise in intracellular calcium after cerebral ischaemia (Fig. 3e). Surprisingly, we also found that SDs that typically occurred 1.5–3 h after the onset of cerebral ischaemia increased microglial process coverage of neuronal cell bodies within 30 min in both neurons showing increasing RCaMP1 signal before and after an SD (termed as Group 1 cells) and in those cells where intracellular calcium returned to near-baseline levels after SD (termed as Group 2 cells; Fig. 3f–h, Supplementary Fig. 9 and Supplementary Video 3). Super-resolution microscopy revealed that fine microglial processes form tight contacts with the neuronal cell body in the evolving infarct, whereas fewer microglia–neuron contacts were seen around the neuronal cell body in sham animals. Microglial P2Y12 receptors were found clustering at the microglia–neuron interface independently of location of astrocyte endfeet (Fig. 3i–j and Supplementary Fig 10). Thus, microglia react rapidly to changes in intracellular calcium in neurons and SD is associated with microglial process recruitment to neurons independently of sustained calcium changes in the injured brain.
Lack of microglia alters neuronal activity and SD after injury
Our imaging data indicated that microglia contact neurons in an activity-dependent manner after brain injury, which led us to investigate neuronal calcium responses in the absence of microglia. To this end, two weeks after GCaMP6s delivery, repeated 2-min-long, fast two-photon imaging recordings were performed by resonant scanning, separated by 5 min breaks over a 5.5–6 h period before and after the induction of 60 min MCAo followed by reperfusion. Selective microglia depletion did not influence GCaMP6s delivery to cortical neurons (456±78 neurons per mm2 in control and 504±35 neurons per mm2 in microglia-depleted mice were GCaMP6s-positive in the imaging area before MCAo being induced). As earlier, we found that cerebral ischaemia resulted in negligible GCaMP6s signal changes in control mice during occlusion and early reperfusion, followed by the occurrence of repeated SDs 1.5–3 h after reperfusion in the evolving infarct. Calcium imaging revealed few changes in individual neurons or in the neuropil before SD (Fig. 4a, left). In contrast, in the absence of microglia striking increases in slow neuronal oscillations were observed 15–25 min after the onset of ischaemia, which continued after the induction of reperfusion up to 3–5 h post MCAo (Fig. 4a right, and Supplementary Video 4). Surprisingly, an absence of microglia was associated with the complete lack of SD in microglia-depleted animals after brain injury (Fig. 4a,b). Hence, average GCaMP6s signal levels did not increase 1.5–3 h after reperfusion as seen in control mice (Fig. 4c). However, cumulative calcium load as calculated by summing up calcium curve integrales from the 2-min resonant scanning sessions of individual neurons over an 5.5 h imaging period, was significantly (over fourfold) higher in microglia-depleted mice compared with controls (Fig. 4d). This difference was striking considering that SDs contributed substantially to cumulative calcium load in control mice, whereas no SDs were seen in the absence of microglia. Moreover, we calculated the time spent before increases in intracellular calcium load become evident in individual neurons, which was markedly shorter in the absence of microglia (Fig. 4e). To investigate whether the increased cumulative calcium load seen in the first hours after ischaemia/reperfusion is associated with subsequent neuronal injury, we investigated the fate of affected neurons at the imaging site 24 h after cerebral ischaemia. We found a significant (20%) reduction in the number of cresyl violet-stained neurons 24 h after cerebral ischaemia in control mice, which was markedly augmented (by over twofold) in microglia-depleted animals (Fig. 4f,g).
Lack of microglia alters neuronal responses to KCl
To test whether an absence of microglia leads to altered neuronal calcium dynamics in the non-ischaemic brain, we applied potassium chloride (KCl) topically to the surface of the cerebral cortex, which is widely used to induce neuronal depolarization and SD19,34. Spontaneous calcium responses before KCl application and calcium responses during SD showed a good correlation with changes in local field potential (Supplementary Fig. 11). In control mice, SD was readily induced within 0.5–3 min after administration of 100 mM KCl with an obvious propagating wavefront as evidenced by GCaMP6s signal changes during fast in vivo two-photon imaging (Fig. 5a,b and Supplementary Video 5). In contrast, similar SD to that seen in control mice was rarely observed in the absence of microglia. In some cases a pale wavefront was seen, resulting from increases of GCaMP6s signal (considered as an SD for quantification) in neuronal cell bodies and the neuropil (Fig. 5b and Supplementary Video 6). Repeated KCl application (three times, over the course of 2 h) resulted in only 20% probability of SD in the absence of microglia as opposed to 80% in animals with functional microglia in the brain (Fig. 5c). Quantitative analysis showed that GCaMP6s signal increases in individual neurons over baseline values after KCl administration took place with significant latency (mean 17 min) in the absence of microglia, compared to control mice (2.5 min, Fig. 5d). In addition, integration of calcium curves of individual neurons revealed a marked reduction in KCl-induced depolarization in microglia-depleted mice (Fig. 5e). Thus, modulation of neuronal activity by microglia-mediated actions appears to be a basic physiological phenomenon that is evident in both the intact and the injured brain.
Lack of microglia does not augment BBB injury after stroke
Since previous studies implicated microglia in vascular injury after cerebral ischaemia9, we tested whether altered BBB injury could be responsible for some of the changes we obsered in microglia-depleted animals. In vivo two-photon recordings of Z-stacks in Cx3Cr1GFP/+ mice with RCaMP1 (Fig. 3b) and histological analysis (Supplementary Fig. 12A) revealed that individual microglial cells extended processes to 6–12 nearby neurons on average, located 15–80 μm away from the microglial cell body. In addition, microglia contacting neurons were often found in the vicinity of capillaries, or extended their processes to distant microvessels. Using Cx3Cr1GFP/+ mice injected intravenously with a red fluorescent tracer, Dextran rhodamine (70,000 molecular weight), we set out to visualize sites of BBB injury that have been associated with altered microglial activity in previous studies25,35. BBB injury at the level of microvessels and arterioles occurred typically 50–90 min after the onset of ischaemia. Microglia located in the vicinity of blood vessels were recruited to the injured sites and displayed an activated phenotype within 15–40 min followed by partial withdrawal of their processes (Supplementary Fig. 12b). However, we found that elimination of microglia did not result in any significant alterations in the kinetics of BBB injury as assessed by in vivo two-photon imaging (Fig. 6) based on the extravasation of intravenously injected Dextran rhodamine in Cx3Cr1GFP/+ mice. Quantitative analysis showed that significant BBB injury in the brain parenchyma takes place 60 min after the onset of ischaemia (analysis of variance, P<0.05) in both control and microglia-depleted animals, but control and microglia-depleted animals did not significantly differ (Fig. 6b). Similarly, no differences were seen in the glia limitans in control versus microglia-depleted mice (Fig. 6c). In addition, an absence of microglia did not alter BBB injury 24 h after MCAo as assessed on coronal brain sections based on leakage of circulating IgG into the brain parenchyma (Fig. 6d). Thus, these data strongly suggest that microglia-mediated protective effects after brain injury are due to the regulation of neuronal activity by microglia and not to effects on the extent or kinetics of vascular injury. We also found blunted upregulation of IL-1α, tumour necrosis factor-α (TNFα), IL-6, monocyte chemoattractant protein-1 (MCP-1), KC (CXCL1) and IL-4 in the ipsilateral hemisphere 8 h after cerebral ischaemia in the absence of microglia (Supplementary Fig. 13), indicating that increased brain injury and changes in neuronal responses are not explained by exaggerated inflammatory responses in this model of microglia depletion.
Here we identify microglia as important components of the neuronal response to brain injury and show that microglia protect against neuronal injury. Selective removal of microglia from the brain leads to the dysregulation of neuronal calcium responses and network activity, increased calcium accumulation and markedly reduced SD incidence after brain injury, which is associated with profoundly increased neuronal loss. Therefore, selective targeting of the pathways involved could have a critical impact on understanding the pathophysiology of common human diseases and the development of novel therapeutic approaches.
The role of microglia in the healthy brain and in neurological diseases remains highly controversial, in spite of the substantial research effort and recent breakthroughs in this field1,2,21. Microglia, the resident immune cells of the brain, appear to be essential for normal brain function, whereas altered microglial function has been linked with diverse brain pathologies in both humans and experimental animals. These include diseases with a high socioeconomic burden such as depression, psychiatric diseases, epilepsy, stroke, migraine, Parkinson’s disease and various forms of dementia such as Alzheimer’s disease2,3,5,6,26,28,36. The controversies regarding the possible detrimental or protective role for microglia in different models of neurological diseases are likely due to multiple factors. Of these, the immunological and functional similarities between microglia and peripheral macrophages have made it difficult, until very recently, to selectively manipulate microglia6,24. Most microglia in the brain are protected by the BBB (except for the cells that reside in the circumventricular organs), and are hence difficult to target, while microglia become rapidly activated in response to any disturbance to the brain or after peripheral inflammatory challenges, which can shape microglial responses and outcome after different forms of brain injury1,5,7. It is important to note that none of the previous studies combined selective microglial depletion with high-resolution two-photon calcium imaging in vivo, to link microglial function with neuronal activity and injury in real time.
We, therefore, established a model of brain injury that allowed us to monitor both microglia–neuron interactions in real time and the effects of microglial depletion on neuronal activity and injury. During preliminary experiments, a model for GCaMP6s delivery was developed to minimize the disturbance of neurons or microglia at the imaging site, while the remote filament model of cerebral ischaemia allowed us to induce targeted injury in the brain without focal surgical intervention in the cerebral cortex. Elimination of microglia using CSF1R blockade was selective, as it did not deplete peripheral myeloid cells, although a small, non-significant reduction in CD11blow Ly6cvhigh monocytes that correspond to ∼2% of total blood leukocytes was noticed. This is unlikely to have a major impact on neuronal activity and injury in this model, especially considering the limited recruitment of monocytes/macrophages compared to microglia in the brain at 24 h reperfusion after transient focal cerebral ischaemia37,38. Depletion of microglia also had minimal impact on other cell types in the brain. This is in line with previous observations using the same approach24, which also demonstrated a lack of illness and behavioural alterations in microglia-depleted animals24,32. This might be due to the cessation of an essential survival signal mediated by CSF1R, leading to the apoptotic death of microglia, without the induction of inflammation. This regimen is expected to cause fewer disturbances to the brain than applying toxic substances that could lead to microglial activation or inflammation. Depletion of microglia by genetic expression of diphtheria toxin could lead to deficits in learning and contextual fear conditioning39, or cause cytokine expression in the brain31, whereas toxicity to hematopoietic cells was observed in CD11b-HSVTK mice in response to ganciclovir40. In addition, microglia ablation by CSF1R blockade did not affect astrocytes, in contrast to observations in microglia-depleted animals using the Cx3Cr1CreER:iDTR model31.
Excitotoxicity is considered to be a major mechanism of neuronal death that occurs due to intracellular calcium overload followed by the activation of various cell death pathways41. After global cerebral ischaemia, rapid, but reversible damage to dendrites and spines was found to be caused by ischaemic depolarizations immediately after cessation of blood flow42. SD was also observed with in vivo calcium imaging propagating from the core of cortical microinfarcts43. We observed delayed occurrence of SD in control mice after focal cerebral ischaemia with small increases in intracellular calcium during MCA occlusion. To our surprise, an absence of microglia completely prevented SD after ischaemia, and markedly reduced the incidence of SD following KCl administration in the non-ischaemic brain. SD has been associated with neuronal injury in stroke, epilepsy, migraine and other forms of brain injury18,19,20,34. In vitro studies on rat hippocampal brain slices have suggested that microglial polarization states could affect the SD threshold44. However, the lack of SD in the ischaemic brain in the absence of microglia in vivo was unexpected. Instead, the development of slow neuronal oscillations as early as 15–25 min after the onset of ischaemia was seen, which was not due to immediate injury to neurons, since slow oscillations were obseved even 2–3 h after reperfusion in the same cells. The majority of the affected neurons died within 24 h in the absence of microglia at the imaging site unlike in control mice, indicating that altered calcium responses could be involved in more pronounced neuronal injury as widely supported by literature data45,46. Due to the lack of research tools to influence SD independently of changing neuronal activity, no mechanistic experiments could be performed in this study to functionally link SD with neuronal injury. However, our data suggest that at least after ischaemia, neuronal death in complex neuronal networks following a series of SDs could be lower than in response to dysregulated neuronal network activity and long-lasting oscillations as seen in the absence of microglia. Altered neuronal responses were observed already 30–45 min before BBB injury in microglia-depleted animals after stroke and were also seen after KCl administration, which does not lead to the disruption of the BBB. Therefore, these data suggest that microglia could impact on neuronal calcium responses and protect against neuronal injury independently of vascular injury. Mice were anaesthetized during imaging, which could alter neuronal responses47. However, control and microglia-depleted mice were exposed to uniformly low isoflurane levels (between 0.8 and 1.1%), hence the anaesthetic is unlikely to contribute to the profoundly altered neuronal responses seen in the absence of microglia. We have not found differences in CBF after MCA occlusion and reperfusion between control and microglia-depleted mice either, although we are aware that laser Doppler measurements only reveal changes in blood flow relative to baseline values in the superficial areas of the cerebral cortex.
We have also investigated whether PLX3397 has any effect on neuronal injury independently of microglia depletion. It has been postulated that CSF1R signalling could contribute to neuronal survival independently of microglia48. However, in our experiments withdrawal of PLX3397 for 24 h, which reduces drug concentrations to below detection level24, while microglia remained depleted, resulted in increased brain injury, similar to that seen in mice fed a PLX3397 diet at the time of MCAo. Increases in brain injury were completely reversed after repopulation of microglia. In addition, acute treatment with a PLX3397 dose higher than that needed to block microglial repopulation24 did not result in depletion of microglia and did not alter brain injury. It is expected that BBB injury after cerebral ischaemia would further increase PLX3397 levels in the brain. These experiments suggest that larger brain injury in this model is due to the absence of functional microglia. Data from previous studies also support our conclusions. Elimination of microglia from rat organotypic slice cultures in a CSF1R-independent manner reduced the incidence of SD, whereas dampening of microglial M1 signalling by minocycline or conditioned medium from M2a-polarized primary microglia led to higher SD threshold44. In addition, inhibition of proliferating microglial cells in CD11b-TKmt-30 transgenic mice resulted in larger ischaemic injury49. The effects of microglia depletion on cerebral perfusion, somatosensory and motor responses, delayed phases of neuronal injury and functional recovery, will need to be investigated in future studies using models of brain injury and neurodegeneration.
The exact molecular mechanisms through which microglia sense and regulate neuronal activity are presently unclear but investigation of the molecular pathways involved extends beyond the scope of this already complex study. It is likely that microglia–neuron signalling involves highly complex interactions between metabolic pathways, neurotransmitters and their receptors, ion channels and inflammatory mediators. Microglia–neuron interactions in the optic tectum of the larval zebrafish were found to be dependent on neuronal pannexin-1 hemichannels and the small Rho GTPase, Rac in microglia50. ATP triggers microglial migration and process extension in both zebrafish larvae and the mammalian brain in vivo8,50. In fact, super-resolution microscopy revealed increased microglial process coverage of neuronal cell bodies after ischaemia and clustering of P2Y12 receptors on fine microglial processes at sites of microglia-neuron contacts, although the functional role of purinergic signalling was not investigated in this study. Glial fibrillary acidic protein (GFAP)-positive astrocyte processes have not been observed at the microglia–neuron interface, but it is possible that some microglial actions on neurons could be mediated via astrocytes. Microglia are known to produce a diverse array of inflammatory mediators that act directly on neurons and impact on neuronal activity and injury. Some of these, such as IL-1 potentiate excitotoxicity and neuronal injury5, while TNFα is known to alter the balance between neuronal excitation and inhibition via different, complementary mechanisms that involve neuronal AMPA, NMDA and GABAA receptors51. Despite larger brain injury, an absence of microglia was associated with blunted ischaemia-induced production of both proinflammatory cytokines (IL-1α, TNFα) and cytokines that are considered to be neuroprotective in the brain (IL-6, IL-4)52,53. Thus, the possible contribution of these cytokines to brain injury remains to be investigated further. The net effect of different microglial actions on neuronal activity and injury could be highly dependent on the dominance of certain pathophysiological mechanisms in different CNS diseases. However, our data are the first to demonstrate that microglia markedly protect neurons against excitotoxicity and injury after cerebral ischaemia in vivo, in spite of the plethora of inflammatory mediators they produce.
Taken together, our results obtained by the combination of high speed in vivo two-photon imaging with selective microglia manipulation revealed a previously unrecognized link between protective microglial actions and neuronal activity and injury. These results could have profound implications on the pathophysiology and potential treatment of major human diseases.
Experiments were carried out in 12–16 weeks old male C57BL/6J and Cx3Cr1GFP/+mice, breeding in the specific-pathogen-free (SPF) unit of the Institute of Experimental Medicine. Animals were allowed free access to food and water and were maintained under controlled temperature, humidity and light conditions. All procedures were in accordance with STAIR and ARRIVE guidelines, and the guidelines set by the European Communities Council Directive (86/609 EEC) and the Hungarian Act of Animal Care and Experimentation (1998; XXVIII, section 243/1998), approved by the Animal Care and Use Committee of the Institute of Experimental Medicine.
Selective elimination and repopulation of microglia
PLX3397 was provided by Plexxikon and formulated in AIN-76A standard chow by Research Diets (290 p.p.m.; 290 mg PLX3397 in 1 kg chow). Mice were fed a PLX3397 diet for 3 weeks to eliminate microglia24. One group of mice was given PLX3397 for 3 weeks, followed by withdrawal of the drug by replacing the PLX3397 diet with control chow diet for 24 h before experiments. Another group of mice was fed PLX3397 for 3 weeks followed by 2 weeks on control diet to allow for the repopulation of microglia in the brain. In agreement with earlier results24, we have not found any obvious behavioural alterations, weight loss or sign of illness in mice fed a PLX3397 diet for 3 weeks or longer. Individual mice were observed for a 5-min period once daily for any changes in activity, exploratory behaviour and social interaction. Baseline temperature was recorded for every mouse before surgery or imaging. No mice were excluded from these studies due to fever, weight loss, infection or behavioural alterations as a result of PLX3397 diet.
AAV vector injection
The injection procedure was performed as described previously54, with some modifications. A 0.5-mm hole was opened in the skull with the tip of a dental drill over the S1 cortical region (centred 1.5 mm lateral and 1.5 mm posterior to the bregma). A glass micropipette was lowered 300 μm under the pia, at a 60° angle towards the imaging area to minimize tissue disturbance at the imaging site, followed by slow injection (300 nl over 5 min) of either AAV1.Syn.GCaMP6s.WPRE.SV40 or AAV1.Syn.RCaMP1h.WPRE.SV40 viral vectors (Penn Vectore Core, Philadelphia, PA; titre 6.32 × 1011 IU ml−1).
Cranial window surgery
Two weeks after injection mice were anaesthetized using isoflurane (3% for induction, 1.5–2% during surgery). First, a custom-made aluminium head plate was fixed to the skull using cyanoarcylate glue and dental cement. Then, the skull was either thinned to 20 μm over the imaging site or a circular craniotomy (3 mm diameter) was made above the S1 cortex (centred 2.7 mm lateral and 1 mm posterior to the bregma) without touching the dura mater. During drilling, the place of craniotomy was rinsed continuously with cold Ringer solution. The location of the imaging window was defined in a separate set of experiments by series of CBF measurements using laser Doppler flowmetry (30 measurements performed at 6 different sites, in n=5 mice). This was done by recording baseline blood flow followed by the occlusion of the MCA with an intraluminal filament for ∼15 s after which reperfusion was induced and the Doppler probe repositioned repeating this procedure several times between the MCA and the midline in the same mouse. The area of the craniotomy was covered with a 3-mm cover glass and fixed with dental cement. In preliminary experiments, microglial activation and neuronal calcium responses were assessed in the case of thinned skull preparations and after craniotomy without dura mater injury. No changes in neuronal calcium signals, microglial CD45, Iba1 or Cx3Cr1 expression were found in either case as opposed to craniotomy with durectomy (Supplementary Fig. 1, and not shown).
Imaging fast calcium responses and BBB injury
All experiments were performed on a Femto2D-DualScanhead microscope (Femtonics Ltd., Budapest, Hungary). Laser pulses were generated by a Mai Tai HP laser (SpectraPhysics, Santa Clara, CA) or by a Chameleon Ultra II laser (Coherent, Inc., Santa Clara, CA). The wavelength was set to 910 nm for GCaMP6s and to 980 nm when RCaMP1 and microglia in Cx3Cr1GFP/+mice were measured simultaneously. For excitation and signal collection, a CFI75 LWD 16XW/0.8 lens (Nikon, 16 ×, NA 0.8) was used, separated using a dichroic mirror (700dcxru, Chroma Technology) before the two channel detector unit, which was sitting on the objective arm (travelling detector system) as described in detail elsewhere55,56. The DualScanhead microscope (Femtonics Ltd., Budapest, Hungary) is coupled with two parallel light paths, which allows imaging at the same imaging site either with a galvanic mirror or with resonant scanner without moving or changing the sample. First, the galvo-scanning light path was used to acquire Z-stacks from 200 to 80 μm under the dura mater, with 12 images per stack at 800 × 800 pixel resolution (0.75 μm per pixel). Then, the light path was changed to the resonant scanning mode and two-photon imaging at video rate (31.25 frames per second) was performed at 512 × 512 pixel resolution (1 μm per pixel) for 60–120 s. This protocol was repeated every 5 min over the whole (5.5–6 h) imaging period for cerebral ischaemia studies. Data acquisition was performed by MesC softver (Femtonics Ltd.). To image microglia in Cx3Cr1GFP/+ mice simultaneously with the assessment of BBB injury the galvo-scanning light path was used. Z-stacks were recorded in the cerebral cortex (same area as used for neuronal calcium measurements) continuously from 200 μm to 110 μm under the dura mater every 3 min for a 5–6 h period before, and after the onset of ischaemia. Integrated density (area of the ROI × the mean of the ROI) was assessed at 6–6 randomly selected areas over the brain parenchyma and the glia limitans in every stack, using ImageJ. Integrated density values were expressed as a percentage of baseline (IntDen%). The occlusion of the MCA during in vivo two-photon imaging was verified by blood flow velocity changes measured using the line-scan mode of the galvo-scanning light path. Dextran rhodamine signal was recorded along a linear scanning trajectory perpendicular to the blood vessels’ wall (measuring a single, 1.5 μm linear line with 3–5 kHz temporal resolution) on the red channel. Blood flow velocity was calculated as earlier57. Three mice in total were excluded from the imaging studies pre hoc, one control mouse after cerebral ischaemia due to improper laser intensity during imaging and two (one control and one microglia depleted) mice from KCl studies due to inappropriate anaesthesia.
SD induction with KCl solution
In one group of mice, a small area of the cranial window was left uncovered laterally to the cover glass (where the dura mater was not injured). The dura mater was focally opened using a syringe needle and SD was induced by applying 100 mM KCl solution to the surface of the brain for 25 min. Three repeated SD induction periods were recorded. During SD induction, animals were continuously imaged with resonant scanning for repeated 2 min periods. Then, a 15-min resting period was put in the protocol when the KCl solution was replaced with Ringer solution until the beginning of the next SD induction. In a set of studies, local field potential was measured simultaneously with GCaMP6s signal changes before and after KCl application, using a borosilicate glass electrode (∼0.1 MΩ) filled with ACSF. Recordings were made in IC mode at 0 mV holding potential.
Remote filament model of MCAo
Cranial window preparation was followed by remote filament implantation under isoflurane anaesthesia. The common carotid, the external carotid and the internal carotid arteries were exposed and the common carotid artery temporarily clipped. A 5 cm long, 5.0 monofilament with silicon rubber coating (210 μm tip diameter), residing in a silicone guiding tube was introduced into the left external carotid artery and advanced along the internal carotid artery up to 8 mm, without occluding the MCA. Blood flow was restored in the common carotid artery and the silicone guiding tube was secured, followed by closure of the wound at the site of surgery, to allow free manipulation of the monofilament during in vivo two-photon imaging. Mice were positioned into the two-photon microscope, after which 15–30 min baseline imaging was performed followed by the induction of 60 min of MCA occlusion and 4–5 h reperfusion.
Middle cerebral artery occlusion
MCAo was performed using the intraluminal filament technique as described earlier58. In brief, animals were anaesthetized with isoflurane and a silicone-coated monofilament (210 μm tip diameter, Doccol, US) was introduced into the left external carotid artery and advanced along the internal carotid artery to occlude the MCA for 45 min. Occlusion was confirmed by a laser Doppler (Moor Instruments, UK). During surgery, core temperature was maintained at 37±0.5 °C. After experimental stroke, four mice were excluded pre hoc due to incomplete occlusion of the MCA or surgical artifacts.
Tissue processing and immunostaining
After terminal anaesthesia, mice were perfused transcardially with saline followed by ice-cold 4% paraformaldehyde. Brains and spleens were post-fixed for 24 h, cryoprotected in 10% sucrose/PBS and sectioned (25 μm diameter) on a sledge microtome. Detection of IgG leakage to the brain parenchyma by immunostaining (Vector, NBA-2000, horse anti-mouse biotynilated IgG 1:500) was used to assess BBB permeability on brain sections as described earlier58. Immunofluorescence was performed on free-floating brain sections using combinations of rabbit anti-Iba1 (WAKO, 019-19741, 1:500), rat anti-CD45 (AbDSerotec, MCA1388, 1:250), mouse anti-GFAP (Sigma, G3893, 1:500), rabbit anti-Claudin-5 (Invitrogen, 34-1600, 1:500) and goat anti-PDGFRβ (R&D Systems, AF1042, 1:500) antibodies. Sections were incubated in a primary antibody cocktail overnight followed by adequate fluorochrome (Invitrogen, A21206, donkey anti-rabbit Alexa 488 1:500; Invitrogen, A21203, donkey-anti-mouse Alexa 594 1:500)-conjugated antibodies. Biotinylated tomato lectin (Sigma-Aldrich, L0651-1 mg, 1:100) was used to visualize blood vessels, followed by streptavidin Alexa 350 conjugate (Invitrogen, S11249, 1:200). Images were captured using a Zeiss Axiovert 200M microscope with Axiovision 4.8 software.
Free-floating brain sections were blocked with 2% normal donkey serum followed by immunostaining with rabbit anti-P2Y12 (Anaspec, AS-55043A, 1:500) antibody and anti-rabbit Alexa 647 secondary antibody (Jackson ImmunoResearch, 711-605-152, 1:400). Neurons were visualized by GCaMP6s signal and astrocytes detected using a mouse anti-GFAP antibody (Sigma, G3893, 1:500) developed by anti-mouse DyLight 405-Streptavidin secondary antibody (Jackson ImmunoResearch, 016-470-084, 1:400). Sections were mounted onto #1.5 borosilicate coverslips and covered with imaging medium containing 5% glucose, 0.1 M mercaptoethylamine, 1 mg ml−1 glucose oxidase, and catalase (Sigma, 1500 U ml−1) in Dulbecco’s PBS (Sigma), immediately before imaging59. STORM imaging was performed for P2Y12 (stimulated by a 647 nm laser) by using a Nikon N-STORM C2+ super-resolution system that combines ‘Stochastic Optical Reconstruction Microscopy’ technology and Nikon’s Eclipse Ti research inverted microscope to reach a lateral resolution of 20 nm and axial resolution of 50 nm (refs 60, 61).
IL-6 was measured in cerebrospinal fluid samples and IL-1α, IL-1β, TNFα, IFNγ, IL-6, MCP-1, RANTES (CCL5), G-CSF, KC (CXCL1), IL-10 and IL-4 were measured in homogenates of saline perfused ipsilateral and contralateral brain hemispheres62 by cytometric bead array using CBA Flex Sets (all from BD Biosciences, 560157, 560232, 558299, 558296, 558301, 558342, 558345, 560152, 558340, 558300, 558294, respectively). Measurements were performed on a BD FACSVerse machine and data analysed using FCAP Array software (BD Biosciences). Brain tissue cytokine levels were corrected for the total protein content of the samples as measured by BCA assay (Pierce).
Following Fc receptor blockade (eBioscience, 16-0161-85 anti-mouse CD16/CD32, 1:100), blood cells and splenic leukocytes cells were stained with cocktails of selected antibodies: T cells (all from eBioscience, 11-0043-82 anti-mouse CD4-FITC, 1:100; 12-0081-82 anti-mouse CD8a-PE, 1:400; 17-0031-80 anti-mouse CD3e-APC, 1:200), B cells (all from eBioscience, 11-0193-81 anti-mouse CD19-FITC, 1:100; 17-5321-81 anti-mouse MHCII (I-A/I-E)-APC, 1:400); granulocytes/monocytes (all from eBioscience, 11-0112-81 anti-mouse CD11b-FITC, 1:100; 25-5932-80 anti-mouse Ly-6C-PE-Cy7, 1:400) and macrophages (BD Biosciences, 563900 rat anti-mouse F4/80-like receptor-Violet, 1:200). Antibodies were purchased from eBioscience. Cells were acquired on a BD FACSVerse flow cytometer (BD Biosciences, US) and data were analysed using FACSuite software (BD Biosciences). Total blood cell counts were calculated by using 15 μm polystyrene microbeads (Polysciences, 18328-5).
Animals were randomized for MCAo experiments using GraphPad Random Number Generator. All quantitative analysis was performed under blinded conditions. The volume of ischaemic brain damage was measured on cresyl violet-stained brain sections. Infarct size and BBB injury at 24 h reperfusion were calculated by integration of areas of damage measured at eight neuroanatomically defined coronal levels (between 2.9 mm rostral and −4.9 mm caudal to bregma) with the distance between coronal levels followed by correction for oedema, as described previously58. Quantitative analysis of immunostaining was performed on at least three, randomly selected fields within the region of interest for each brain section, on 4-4 serial coronal sections separated by 400 μm for the striatum and 800 μm for the cerebral cortex (between 0.8 posterior and 0.8 anterior and between 2.4 posterior and 0.8 anterior to the bregma, respectively). The border of infarct was defined on cresyl violet-stained brain sections and microglial activation was also visualized on adjacent sections based on Iba1 immunofluorescence. Two-photon image sequences were analysed using ImageJ. Measurement units were collected from MesC files with HDF5 importer plugin. Background intensity was measured in a dark region of the field of view and was subtracted from each image sequence. The GCaMP6s signal of individual neurons was collected with ImageJ Plot-axis Z profile into the MES (Femtonics Ltd.) curve analysis modul. The trace of the individual cells was normalized to the baseline level of signal (a time interval without calcium activity, typically the begining of the imagig sequence). Then, the area under the curve was calculated for calcium curves after cerebral ischaemia or SD induction with KCl. Microglia-neuron interactions were assessed on Z-stacks recorded every 3 min between 200 and 11 μm under the dura mater. Microglia contacting neurons were randomly selected and neurons showing at least 1.5-foldchange in RCaMP1 signal were used to study microglial process recruitment over a 150 min period after the onset of ischaemia. The net extension/withdrawal of microglial processes to individual neurons was plotted against relative RCaMP1 signal intensity changes measured during the same period. Changes in microglial ramification were investigated with Sholl analysis as described earlier33. Two-photon images of individual microglial cells were converted into a minimum intensity projection image using the concentric circles plugin of the ImageJ with a 2 μm step size. The intercesctions between the circles and the cell processes were calculated manually for each cell. To evaluate microglia process recruitment to neuronal soma, a concentric circle macro (modification of a Sholl analysis) was written for Fiji. Microglia process coverage around neurons was assessed in 30 circles (0.5 μm step size) with an r step of 4. For three-dimensional reconstruction of in vivo two-photon images at different Z-planes to visualize the relationship between neuronal RCaMP1 and microglial processes in Cx3Cr1GFP/+mice, the Simple Neurite Tracer plugin (Fiji) was used.
Group sizes for MCAo studies with infarct size assessment were determined by power calculation (GPower 3.1) based on results from our representative previous studies (α error probability: 0.05, power: 0.8 and an estimated 20% s.d.). This resulted in n=7 for two experimental groups (Cohen’s d effect size: 1.66) and n=9 for four experimental groups (effect size f: 0.6). No formal power calculation was performed for imaging studies. Data were analysed using Student’s t-test or Mann–Whitney test (comparing two experimental groups), one-way or two-way analysis of variance followed by Tukey’s and Sidak’s post hoc comparison, respectively (comparing three or more groups) and linear regression was used for correlation analysis (GraphPad Prism 6.0). P<0.05 was considered statistically significant.
How to cite this article: Szalay, G. et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat. Commun. 7:11499 doi: 10.1038/ncomms11499 (2016).
Kettenmann, H., Hanisch, U. K., Noda, M. & Verkhratsky, A. Physiology of microglia. Physiol. Rev. 91, 461–553 (2011).
Block, M. L., Zecca, L. & Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57–69 (2007).
Dheen, S. T., Kaur, C. & Ling, E. A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14, 1189–1197 (2007).
Iadecola, C. & Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796–808 (2011).
Denes, A., Thornton, P., Rothwell, N. J. & Allan, S. M. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 24, 708–723 (2010).
Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312 (2014).
Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318 (2005).
Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752–758 (2005).
Jolivel, V. et al. Perivascular microglia promote blood vessel disintegration in the ischaemic penumbra. Acta Neuropathol. 129, 279–295 (2015).
Winship, I. R. & Murphy, T. H. In vivo calcium imaging reveals functional rewiring of single somatosensory neurons after stroke. J. Neurosci. 28, 6592–6606 (2008).
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischaemic terminals. J. Neurosci. 29, 3974–3980 (2009).
Eyo, U. B. et al. Modulation of microglial process convergence toward neuronal dendrites by extracellular calcium. J. Neurosci. 35, 2417–2422 (2015).
Kaindl, A. M. et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann. Neurol. 72, 536–549 (2012).
Mohebiany, A. N. & Schneider, R. Glutamate excitotoxicity in the cerebellum mediated by IL-1beta. J. Neurosci. 33, 18353–18355 (2013).
Turrin, N. P. & Rivest, S. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26, 143–151 (2006).
Vinet, J. et al. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 9, 27 (2012).
Dreier, J. P. & Reiffurth, C. The stroke-migraine depolarization continuum. Neuron 86, 902–922 (2015).
Dreier, J. P. The role of spreading depression, spreading depolarization and spreading ischaemia in neurological disease. Nat. Med. 17, 439–447 (2011).
Dreier, J. P. et al. Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain 135, 259–275 (2012).
Hinzman, J. M., DiNapoli, V. A., Mahoney, E. J., Gerhardt, G. A. & Hartings, J. A. Spreading depolarizations mediate excitotoxicity in the development of acute cortical lesions. Exp. Neurol. 267, 243–253 (2015).
Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).
Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013).
Erblich, B., Zhu, L., Etgen, A. M., Dobrenis, K. & Pollard, J. W. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS ONE 6, e26317 (2011).
Elmore, M. R. et al. Colony-stimulating factor 1 receptor signalling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380–397 (2014).
Fumagalli, S., Perego, C., Ortolano, F. & De Simoni, M. G. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61, 827–842 (2013).
Frakes, A. E. et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009–1023 (2014).
Neher, J. J. et al. Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc. Natl Acad. Sci. USA 110, E4098–E4107 (2013).
Faustino, J. V. et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J. Neurosci. 31, 12992–13001 (2011).
Neumann, J. et al. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. 28, 5965–5975 (2008).
Goldmann, T. et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16, 1618–1626 (2013).
Bruttger, J. et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 43, 92–106 (2015).
Rice, R. A. et al. Elimination of microglia improves functional outcomes following extensive neuronal loss in the hippocampus. J. Neurosci. 35, 9977–9989 (2015).
Morrison, H. W. & Filosa, J. A. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J. Neuroinflammation 10, 4 (2013).
Farkas, E., Pratt, R., Sengpiel, F. & Obrenovitch, T. P. Direct, live imaging of cortical spreading depression and anoxic depolarisation using a fluorescent, voltage-sensitive dye. J. Cereb. Blood Flow Metab. 28, 251–262 (2008).
Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323–3328 (2011).
Brown, G. C. & Neher, J. J. Microglial phagocytosis of live neurons. Nat. Rev. Neurosci. 15, 209–216 (2014).
Schilling, M. et al. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 183, 25–33 (2003).
Denes, A. et al. Central and haematopoietic interleukin-1 both contribute to ischaemic brain injury in mice. Dis. Model. Mech. 6, 1043–1048 (2013).
Parkhurst, C. N. et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596–1609 (2013).
Heppner, F. L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146–152 (2005).
Sattler, R. & Tymianski, M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107–129 (2001).
Murphy, T. H., Li, P., Betts, K. & Liu, R. Two-photon imaging of stroke onset in vivo reveals that NMDA-receptor independent ischemic depolarization is the major cause of rapid reversible damage to dendrites and spines. J. Neurosci. 28, 1756–1772 (2008).
Shih, A. Y. et al. The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat. Neurosci. 16, 55–63 (2013).
Pusic, K. M., Pusic, A. D., Kemme, J. & Kraig, R. P. Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment. Glia 62, 1176–1194 (2014).
Bano, D. & Nicotera, P. Ca2+ signals and neuronal death in brain ischemia. Stroke 38, 674–676 (2007).
Lai, T. W., Zhang, S. & Wang, Y. T. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog. Neurobiol. 115, 157–188 (2014).
Heinke, W. & Koelsch, S. The effects of anesthetics on brain activity and cognitive function. Curr. Opin. Anaesthesiol. 18, 625–631 (2005).
Luo, J. et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210, 157–172 (2013).
Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y. C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischaemic injury in the brain. J. Neurosci. 27, 2596–2605 (2007).
Li, Y., Du, X. F., Liu, C. S., Wen, Z. L. & Du, J. L. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev. Cell 23, 1189–1202 (2012).
Olmos, G. & Llado, J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014, 861231 (2014).
Jung, J. E., Kim, G. S. & Chan, P. H. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 42, 3574–3579 (2011).
Gadani, S. P., Cronk, J. C., Norris, G. T. & Kipnis, J. IL-4 in the brain: a cytokine to remember. J. Immunol. 189, 4213–4219 (2012).
Chen, T. W. et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499, 295–300 (2013).
Katona, G. et al. Fast two-photon in vivo imaging with three-dimensional random-access scanning in large tissue volumes. Nat. Methods 9, 201–208 (2012).
Chiovini, B. et al. Dendritic spikes induce ripples in parvalbumin interneurons during hippocampal sharp waves. Neuron 82, 908–924 (2014).
Drew, P. J., Blinder, P., Cauwenberghs, G., Shih, A. Y. & Kleinfeld, D. Rapid determination of particle velocity from space-time images using the Radon transform. J. Comput. Neurosci. 29, 5–11 (2010).
Denes, A., Humphreys, N., Lane, T. E., Grencis, R. & Rothwell, N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 30, 10086–10095 (2010).
Dani, A., Huang, B., Bergan, J., Dulac, C. & Zhuang, X. Superresolution imaging of chemical synapses in the brain. Neuron 68, 843–856 (2010).
Dudok, B. et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat. Neurosci. 18, 75–86 (2015).
Barna, L. et al. Correlated confocal and super-resolution imaging by VividSTORM. Nat. Protoc. 11, 163–183 (2016).
Denes, A. et al. Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibalpha. Ann. Neurol. 75, 670–683 (2014).
Funding was provided by OTKA K109743 (A.D.) and the Hungarian Brain Research Program KTIA_13_NAP-A-I/2 (A.D.). A.D. is supported by the Bolyai Janos Research Scholarship from the Hungarian Academy of Sciences. The authors thank the Hungarian-French grant (TÉT_10-1-2011-0389), OTKA (K105997), FP7-ICT-2011-C 323945 (3 × 3Dimaging), VKSZ_14-1-2015-0155, ERC 682426, KTIA_NAP_13-2-2015-0006 and Swiss-Hungarian grant (SH/7/2/8) for additional support. We thank the Cell Biology Center (Flow Cytometry Core Facility) at the Institute of Experimental Medicine of the Hungarian Academy of Sciences, Budapest, Hungary for their assistance and Csaba Dávid for his help in the development of macros used for analysis of microglia process coverage. We thank László Barna, Vivien Miczán and the NMC Imaging Center at the Institute of Experimental Medicine for kindly providing microscopy support.
B.L.W. is an employee of Plexxikon. G.K. and B.R. are founders of Femtonics Kft. B.R. is a member of its scientific advisory board.
Supplementary Figures 1-13 (PDF 1721 kb)
Spreading depolarization induced after cerebral ischemia in the cerebral cortex. In vivo two-photon imaging of GCaMP6s signal changes showing induction of spreading depolarization in the cerebral cortex after cerebral ischemia (see Figure 2E for details). Imaging was performed with resonant scanning at 31.25 frames / s. (MOV 28257 kb)
Microglia react rapidly to changes in neuronal intracellular calcium levels after cerebral ischemia. Increases in neuronal RCaMP1 signal (white to-magenta, pseudocolored) are associated with microglial process extension (green) after cerebral ischemia in Cx3Cr1GFP/+ (microglia reporter) mice (see Figure 3C for details). In vivo two-photon images were recorded with Galvo scanning every 3 min. (MOV 468 kb)
Microglial process recruitment to neuronal cell bodies increases rapidly after spreading depolarization. Neuronal RCaMP1 signal (white, pseudocolored) showing spreading depolarization (SD), which is followed by microglial process recruitment (green) after cerebral ischemia in Cx3Cr1GFP/+ (microglia reporter) mice (see Figure 3F for details). In vivo two-photon images were recorded with Galvo scanning every 3 min. (MOV 268 kb)
Absence of microglia leads to slow neuronal oscillations and lack of spreading depolarization after cerebral ischemia in the cerebral cortex. In vivo two-photon imaging of GCaMP6s signal changes showing the development of slow neuronal oscillations, which is associated with lack of spreading depolarization in the cerebral cortex after cerebral ischemia in microglia-depleted animals (see Figure 4A for details). Imaging was performed with resonant scanning at 31.25 frames /s. (MOV 30035 kb)
Spreading depolarization induced by KCl in the cerebral cortex. In vivo two-photon imaging of GCaMP6s signal changes showing induction of spreading depolarization in the cerebral cortex after administration of 100 mM KCl (see Figure 5A for details). Imaging was performed with resonant scanning at 31.25 frames /s. (MOV 18799 kb)
Absence of microglia reduces spreading depolarization after KCl administration in the cerebral cortex. In vivo two-photon imaging of GCaMP6s signal changes reveals inhibition of spreading depolarization in the cerebral cortex after administration of 100 mM KCl (see Figure 5A for details) in microgliadepleted animals. Imaging was performed with resonant scanning at 31.25 frames /s. (MOV 24138 kb)
About this article
Cite this article
Szalay, G., Martinecz, B., Lénárt, N. et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun 7, 11499 (2016). https://doi.org/10.1038/ncomms11499
Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation
Journal of Neuroinflammation (2022)
Acta Neuropathologica (2022)
Acta Neuropathologica (2022)
Can quantifying morphology and TMEM119 expression distinguish between microglia and infiltrating macrophages after ischemic stroke and reperfusion in male and female mice?
Journal of Neuroinflammation (2021)
Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study
Journal of Neuroinflammation (2021)